Tefillin use induces remote ischemic preconditioning pathways in healthy men

Area of Science:

• Cardiovascular Physiology
• Immunology
• Preventive Medicine

Background:

• Remote ischemic preconditioning (RIPC) has shown cardiovascular benefits but lacks clinical translation.
• Orthodox Jewish men, daily tefillin users, exhibit lower cardiovascular mortality than non-users.
• Tefillin use involves nonocclusive arm wrapping, potentially mimicking RIPC.

Purpose of the Study:

• To investigate if tefillin use induces a remote ischemic preconditioning (RIPC)-like effect.
• To compare vascular reactivity and inflammatory markers between daily tefillin users and non-users.
• To assess the impact of acute tefillin application on vascular function.

Main Methods:

• A pilot study involving 20 Jewish men (9 daily tefillin users, 11 controls).
• Assessment of vital signs, circulating cytokines, monocyte function, and brachial flow-mediated dilation.
• Measurements taken at baseline and after 30 minutes of acute tefillin use.

Main Results:

• Chronic tefillin users showed higher systolic velocity at baseline compared to controls.
• Acute tefillin use improved brachial artery diameter and blood flow in both groups.
• Conditioned subjects exhibited reduced baseline inflammation, monocyte migration/adhesion, and endothelial activation.

Conclusions:

• Acute tefillin use enhances vascular function.
• Chronic tefillin use is associated with an anti-inflammatory, RIPC-like phenotype.
• Tefillin use may contribute to the observed cardiovascular benefits in Orthodox Jewish men.